EGFR and non-small cell lung carcinoma: To determine whether EGFR mutation status was important in the regulation of FASN for survival of TKI‐resistant NSCLC cells, isogenic PC‐9 cells as well as H1975 and H1703 cells were selected, as they possess distinct EGFR status and response to Gefitinib exposure.